Breathe Well Live Well
|
Dr Reddy's Laboratories launches generic anti-asthma drug in US market
Economic Times NEW DELHI: Drug maker Dr Reddy's Laboratories has launched its generic Montelukast Sodium oral granules used for treating asthma and seasonal allergies in the US market. The launch was made on September 26 following approval by the United States … |
View full post on asthma – Google News
|
Dr. Reddy's Laboratories launches Zafirlukast tablets in US
Trading Markets (press release) … Laboratories (NYSE: RDY | PowerRating) reported on Saturday the launch of its Zafirlukast tablets (10mg and 20mg) in the US market, for treating asthma. … Dr Reddy's gets USFDA nod Dr. Reddy's launches generic Accolate Dr Reddy's gets FDA nod to launch Zafirlukast in US |
View full post on asthma – Google News